Susi Roger E. 4

What Happened

• Roger E. Susi, a 10% owner of IRADIMED CORP (IRMD), sold a total of 5,000 shares in open‑market transactions on January 26, 2026. The sales were: 4,339 shares at a weighted average price of $100.54 (proceeds $436,243) and 661 shares at a weighted average price of $101.38 (proceeds $67,012), for combined proceeds of approximately $503,255.
• The sales were executed pursuant to a Rule 10b5‑1 trading plan adopted by Mr. Susi on June 16, 2025.

Key Details

• Transaction dates: January 26, 2026 (reported on Form 4 filed Jan 27, 2026).
• Prices reported: $100.54 (weighted avg for the 4,339‑share block; individual trades ranged $100.05–$100.95) and $101.38 (weighted avg for the 661‑share block; trades ranged $101.14–$101.65). The filer offers to provide per‑trade details upon request.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Notable footnotes: Sales were made under a pre‑arranged 10b5‑1 plan (adopted June 16, 2025). The filer disclaims beneficial ownership except to the extent of pecuniary interest.
• Filing timeliness: Report filed the day after the transactions (no late filing indicated).

Context

• Sales under 10b5‑1 plans are pre‑scheduled trading programs and are commonly used for routine disposition of shares; they do not, by themselves, indicate a change in the insider’s view of the company.
• As a 10% owner (rather than an executive transaction), these sales reflect disposition by a significant holder and are reported under Section 16 rules.